Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Preferred Shares (2020)

Inmune Bio's Preferred Shares history spans 1 years, with the latest figure at $10.0 million for Q4 2020.

  • For Q4 2020, Preferred Shares changed N/A year-over-year to $10.0 million; the TTM value through Dec 2020 reached $10.0 million, changed N/A, while the annual FY2020 figure was $10.0 million, N/A changed from the prior year.
  • Preferred Shares for Q4 2020 was $10.0 million at Inmune Bio.
  • Across five years, Preferred Shares topped out at $10.0 million in Q4 2020 and bottomed at $10.0 million in Q4 2020.